Imunon (NASDAQ:IMNN) Earns Buy Rating from D. Boral Capital
D. Boral Capital reissued their buy rating on shares of Imunon (NASDAQ:IMNN – Free Report) in a research report released on Wednesday,Benzinga reports. D. Boral Capital currently has a $29.00 price target on the stock. Separately, HC Wainwright reiterated a “buy” rating and set a $14.00 price objective on shares of Imunon in a research […]
